Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers
- 1 October 1996
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 42 (4) , 503-506
- https://doi.org/10.1111/j.1365-2125.1996.tb00015.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Intestinal effects of α‐glucosidase inhibitors: absorption of nutrients and enterohormonal changesEuropean Journal of Clinical Investigation, 1994
- An evaluation of the potential side‐effects of α‐glucosidase inhibitors used for the management of diabetes mellitusEuropean Journal of Clinical Investigation, 1994
- Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM PatientsDiabetes Care, 1994
- Now what?American Journal of Physiology-Cell Physiology, 1993
- α-Glucosidase Inhibition by Miglitol in NIDDM PatientsDiabetes Care, 1992
- The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?British Journal of Clinical Pharmacology, 1990
- Postprandial Glycemic Control, Hormonal Effects and Carbohydrate Malabsorption during Long-Term Administration of the Alpha-Glucosidase Inhibitor MiglitolDigestion, 1990
- Effects of 8-Wk α-Glucosidase Inhibition on Metabolic Control, C-Peptide Secretion, Hepatic Glucose Output, and Peripheral Insulin Sensitivity in Poorly Controlled Type II Diabetic PatientsDiabetes Care, 1989
- Plasma Insulin and Glucose Responses of Healthy Subjects to Varying Glucose Loads During Three-hour Oral Glucose Tolerance TestsDiabetes, 1970